相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Marcel Kool et al.
CANCER CELL (2014)
Cytogenetic Prognostication Within Medulloblastoma Subgroups
David J. H. Shih et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Cerebellar Mutism After Posterior Fossa Tumor Resection Case Discussion and Recommendations for Psychoeducational Intervention
Sarah G. Ross et al.
JOURNAL OF PEDIATRIC ONCOLOGY NURSING (2014)
Therapeutic Targeting of Developmental Signaling Pathways in Medulloblastoma: Hedgehog, Notch, Wnt and Myc
Eric Raabe et al.
Current Signal Transduction Therapy (2013)
Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study
Carsten Friedrich et al.
EUROPEAN JOURNAL OF CANCER (2013)
Protons for Craniospinal Radiation: Are Clinical Data Important?
Suzanne L. Wolden
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031)
Nancy J. Tarbell et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961
Roger J. Packer et al.
NEURO-ONCOLOGY (2013)
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
Jun Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934
David M. Ashley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Factors Predicting the Need for Cerebrospinal Fluid Diversion following Posterior Fossa Tumor Surgery in Children
C. V. Gopalakrishnan et al.
PEDIATRIC NEUROSURGERY (2012)
Hedgehog pathway as a drug target: Smoothened inhibitors in development
Tara L. Lin et al.
ONCOTARGETS AND THERAPY (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
Gerrit J. P. Dijkgraaf et al.
CANCER RESEARCH (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
DISEASE CONTROL AND OTOTOXICITY USING INTENSITY-MODULATED RADIATION THERAPY TUMOR-BED BOOST FOR MEDULLOBLASTOMA
William R. Polkinghorn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
Andre O. von Bueren et al.
NEURO-ONCOLOGY (2011)
Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
Tarek Shalaby et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials
Barry L. Pizer et al.
BRITISH JOURNAL OF NEUROSURGERY (2009)
Pediatric medulloblastoma: Toxicity of current treatment and potential role of protontherapy
Piero Fossati et al.
CANCER TREATMENT REVIEWS (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy
C. S. Chung et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the Head Start I and II protocols
Girish Dhall et al.
PEDIATRIC BLOOD & CANCER (2008)
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity
Roberta Castriconi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology, Group
Patricia L. Robertson et al.
JOURNAL OF NEUROSURGERY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis
MD Castellone et al.
SCIENCE (2005)
Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
XN Li et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Neurocognitive consequences of risk-adapted therapy for childhood medulloblastorna
RK Mulhern et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management - A Canadian Pediatric Brain Tumor Consortium Study
U Tabori et al.
CANCER (2005)
Reducing toxicity from craniospinal irradiation: Using proton beams to treat medulloblastoma in young children
GE Yuh et al.
CANCER JOURNAL (2004)
The treatment of adults with medulloblastoma: A prospective study
AA Brandes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Histopathologic grading of medulloblastomas - A pediatric oncology group study
CG Eberhart et al.
CANCER (2002)
Guidelines for prevention of Pneumocystis carinii pneumonitis in children and adolescents with cancer.
AH Groll et al.
KLINISCHE PADIATRIE (2001)
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood:: Results of the German prospective randomized trial HIT '91
RD Kortmann et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
